Breast Cancer

Filters

Online Exclusive

SALE UP TO 25% OFF

Shop The Sale
全部清除

图卡替尼（Tukadx）150mg —— HER2 阳性乳腺癌 | GLT

老挝大熊制药仿制图卡替尼（Tukadx），用于 HER2 阳性转移性乳腺癌。

图卡替尼（Tukanic）150mg —— HER2 阳性乳腺癌 | GLT

齐斯卡制药（Ziska）平价的仿制图卡替尼（Tukanic），用于 HER2 阳性转移性乳腺癌。

图卡替尼（LuciTuca）150mg —— HER2 阳性乳腺癌 | GLT

卢修斯制药仿制图卡替尼（LuciTuca），用于 HER2 阳性转移性乳腺癌。

图卡替尼（PHOTUCA）50mg/150mg —— HER2 阳性乳腺癌 | GLT

老挝第二制药厂仿制图卡替尼（PHOTUCA），用于 HER2 阳性转移性乳腺癌。

图卡替尼（Tukysa）—— HER2 阳性乳腺癌 | GLT

获 FDA 批准的 HER2 酪氨酸激酶抑制剂，用于 HER2 阳性转移性乳腺癌。

图卡替尼（Tucaxen）150mg —— HER2 阳性乳腺癌 | GLT

珠峰制药（Everest）平价的仿制图卡替尼（Tucaxen），用于 HER2 阳性转移性乳腺癌。

LuciEver (Everolimus) 5mg/10mg Tablets | Laos Generic mTOR Inhibitor | GLT

Lucius Laos generic everolimus for RCC, neuroendocrine tumors and TSC

Ribociclib (Kisqali) 200mg*21's/14's | Novartis Switzerland | GLT

Novartis Switzerland originator Kisqali (ribociclib) 200mg, 21-tablet and 14-tablet packs for HR+/HER2- breast cancer.

Ribociclib (LuciRibo) 200mg*21's | Lucius Laos Generic | GLT

LuciRibo — Lucius Pharmaceuticals ribociclib 200mg 21 tablets for HR+/HER2- breast cancer.

Ribociclib (HER-2N) 200mg*21's | Julphar Bangladesh Generic | GLT

HER-2N — Julphar Bangladesh ribociclib 200mg 21 tablets, DGDA-certified, for HR+/HER2- breast cancer.

Acestrant for Advanced and Metastatic Breast Cancer (ABC) | LUCIUS (Lao) Info

Acestrant for Advanced and Metastatic Breast Cancer (ABC) | Menarini Info

Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche Switzerland Originator | GLT

Roche originator Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, HER2-targeted ADC for HER2-positive breast...

UJVIRA Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Zydus India Biosimilar | GLT

Zydus UJVIRA ado-trastuzumab emtansine (T-DM1) biosimilar 100mg & 160mg vials, world's first T-DM1 biosimilar ADC...

LuciAlpe (Alpelisib) 150mg 28 Tablets | Lucius Laos Generic | GLT

LuciAlpe by Lucius Pharmaceuticals (Lao) — Lao FDA registered (03 L 1076/24) generic alpelisib, 150mg...

Vijoice (Alpelisib) 50mg/125mg/200mg Tablets | FDA-Approved PROS Therapy | GLT

Vijoice by Novartis — the first and only FDA-approved treatment for PIK3CA-Related Overgrowth Spectrum (PROS),...
售罄

Afinitor (Everolimus) 2.5mg/5mg/10mg Tablets | mTOR Inhibitor | GLT

Novartis originator everolimus in three strengths for RCC, NET and TSC
售罄

飞尼妥（依维莫司）5mg 片剂 | 中国来源 mTOR 抑制剂 | GLT

中国注册的诺华依维莫司 5mg，用于肾细胞癌和神经内分泌肿瘤。
售罄

Qingweishi (Everolimus) 2.5mg Tablets | First Chinese Generic | GLT

CTTQ first generic everolimus, bioequivalent to Afinitor, for RCC and NET
售罄

Ribociclib (Kisqali) 200mg*21's | Novartis Taiwan, China | GLT

Novartis originator Kisqali (ribociclib) 200mg 21 tablets for HR+/HER2- breast cancer, Taiwan-sourced.
«12»
排序
  • 推荐
  • 价格由低到高
  • 价格由高到底
  • 最新
  • 销量最高